MET and hepatocellular carcinoma: Several biological mechanisms have been reported that MET probably plays a direct anti-tumor role by inhibiting HCC proliferation through induction of G1/G0 phase arrest of the cell cycle, p21CIP and p27KIP expression, and downregulation of cyclin D1 expression [10].